Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01736345 · ClinicalTrials.gov registry record
A Study of the Communication of Genetic Test Results By Telephone: A Multi-Center Study
A clinical trial, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- 289
- Enrollment target
NCT01736345 is a clinical trial that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 289 participants.
The verdict
NCT01736345 has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- 289 participants
- Enrollment target
Study Summary
The overall goal of the proposed research is to evaluate psychosocial and behavioral outcomes (i.e.risks and benefits) of an innovative and efficient delivery model for genetic testing, telephone communication, as an alternative to in-person communication of genetic testing results to inform guidelines regarding the delivery of genetic information in clinical medicine.
Interventions
- GENETIC Genetic Providers
- OTHER Visual Aids
- OTHER Post-Disclosure Asessments
- OTHER In-person Clinical Follow-Up
- OTHER 6 Month and 12 Month Assessments
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 289 participants |
| Start Date | 2012-12-03 |
| Est. Completion | 2015-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01736345
The ClinicalTrials.gov registry entry for NCT01736345 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 289 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Genetic Providers is the first listed.
NCT01736345 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01736345 about?
NCT01736345 is a clinical study titled "A Study of the Communication of Genetic Test Results By Telephone: A Multi-Center Study". The overall goal of the proposed research is to evaluate psychosocial and behavioral outcomes (i.e.risks and benefits) of an innovative and efficient delivery model for genetic testing, telephone communication, as an alternative to in-person communication of genetic testing results to inform guideli...
What is the current status of trial NCT01736345?
This trial is currently completed. The enrollment target is 289 participants. The study started on 2012-12-03. Estimated completion is 2015-11.
What interventions are being tested in trial NCT01736345?
The interventions under investigation include: Genetic Providers (GENETIC), Visual Aids (OTHER), Post-Disclosure Asessments (OTHER), In-person Clinical Follow-Up (OTHER), 6 Month and 12 Month Assessments (OTHER).
Who is sponsoring clinical trial NCT01736345?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.